TrumpRx.gov Launches: 40 Drugs See 70-90% Price Drops (February 2026 Update)
On February 5, 2026, the White House officially launched TrumpRx.gov, a historic platform designed to end "price gouging" of American patients. By implementing a Most-Favored-Nation (MFN) pricing model, the administration is bringing the costs of the 40 most expensive branded medicines in the U.S. in line with the lowest prices paid in other developed countries.
According to the official White House Fact Sheet, five major pharmaceutical manufacturers have already reached deals with the administration: AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk, and Pfizer.
2026 TrumpRx Price List: GLP-1 and Obesity Medications
The most dramatic savings on the platform are for GLP-1 medications, which previously cost American patients over $1,000 per month.
| Medication | Former List Price | New TrumpRx Price (Starting Feb 2026) |
| Wegovy (Injectable) | $1,349 | As low as $199 (Avg. $350) |
| Wegovy (Oral / Pill / Tablet) | $1,349 | As low as $149 |
| Ozempic | $1,028 | As low as $199 (Avg. $350) |
| Zepbound | $1,088 | As low as $299 (Avg. $346) |
Prices vary based on dosage strength. For those following the next-generation Retatrutide pipeline, analysts expect similar MFN pricing to apply once the "Triple G" molecule receives FDA approval.
Fertility, Respiratory, and Specialty Drug Savings
Beyond weight loss, TrumpRx.gov is targeting high out-of-pocket costs for families and chronic disease patients.
- Fertility Breakthrough: Patients struggling with infertility can now save over $2,000 per cycle.
- Gonal-F: Reduced to as low as $168 per pen.
- Cetrotide: Slashed from $316 to $22.50.
- Ovidrel: Dropped from $251 to $84.
- Respiratory Care:
- Bevespi Aerosphere (COPD): Discounted from $458 to $51.
- Airsupra (Asthma): Slashed from $504 to $201.
- Daily Essentials:
- Insulin Lispro: Available for as low as $25 per month.
- Duavee (Osteoporosis/Hot Flashes): Slashed from $202 to $30.
How Does TrumpRx.gov Work?
The platform provides a streamlined, digital experience for patients with a valid prescription. Depending on the manufacturer, patients can access these historic discounts through two primary channels:
- Digital Gold Coupons: Patients can download or print user-friendly coupons directly from TrumpRx.gov to be used at retail pharmacies.
- Integrated Manufacturer Channels: The portal is directly integrated with manufacturer-led delivery systems (like LillyDirect or PfizerForAll) to ensure low-cost home delivery.
The Road to MFN Pricing: A Timeline
The launch of TrumpRx.gov is the culmination of a multi-step strategy by the Trump Administration to lower costs:
- May 12, 2025: Executive Order signed to establish Most-Favored-Nation pricing.
- December 1, 2025: An agreement with the United Kingdom was reached to ensure they pay their "fair share," increasing their drug prices by 25% to offset American costs.
- January 15, 2026: President Trump called on Congress to codify these savings into The Great Healthcare Plan.
What This Means for the Future (Retatrutide)
The establishment of the TrumpRx infrastructure creates a "pre-set" path for newer medications. As Retatrutide (the Triple G molecule) completes its Phase 3 TRIUMPH trials throughout 2026, it is expected to be one of the first "new" drugs added to the MFN pricing model.
For patients currently waiting for the most potent weight loss drug ever studied, TrumpRx ensures that the eventual launch of Retatrutide will be affordable for the average American, not just the wealthy.